Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to mechanical stimulus"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
BCL2 | B-cell CLL/lymphoma 2 | 0.999 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.998 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.997 | ||
BCL2L1 | BCL2-like 1 | 0.996 | Human | |
TRAF1 | TNF receptor-associated factor 1 | 0.990 | ||
MAPK14 | mitogen-activated protein kinase 14 | 0.988 | Human | |
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.986 | Human | |
FADD | Fas (TNFRSF6)-associated via death domain | 0.983 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.975 | Human | |
MYD88 | myeloid differentiation primary response gene (88) | 0.971 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.915 | Human | |
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.913 | Human | |
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.893 | ||
XIAP | X-linked inhibitor of apoptosis | 0.860 | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.859 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.822 | Human | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.759 | ||
IL1R1 | interleukin 1 receptor, type I | 0.758 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.713 | Human | |
BCL3 | B-cell CLL/lymphoma 3 | 0.687 | ||
APAF1 | apoptotic peptidase activating factor 1 | 0.664 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.653 | ||
ATF2 | activating transcription factor 2 | 0.643 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.643 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.636 | ||
CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.588 | ||
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.508 | ||
BID | BH3 interacting domain death agonist | 0.502 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.458 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.429 | ||
GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.428 | ||
BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.402 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.379 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.376 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.362 | Human | |
TP53 | tumor protein p53 | 0.350 | ||
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.345 | Human | |
GBP2 | guanylate binding protein 2, interferon-inducible | 0.340 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.337 | ||
TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.328 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.324 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.321 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.316 | ||
GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 0.303 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.302 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.297 | ||
IRF1 | interferon regulatory factor 1 | 0.295 | ||
STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.294 | ||
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 0.288 | Human | |
PLAU | plasminogen activator, urokinase | 0.283 | ||
TRADD | TNFRSF1A-associated via death domain | 0.270 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.269 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.267 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.256 | ||
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.250 | ||
NOSTRIN | nitric oxide synthase trafficker | 0.245 | ||
PRKD2 | protein kinase D2 | 0.244 | ||
HSPB8 | heat shock 22kDa protein 8 | 0.242 | ||
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.241 | ||
LRDD | leucine-rich repeats and death domain containing | 0.236 | ||
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.214 | Human | |
ARRB2 | arrestin, beta 2 | 0.212 | ||
MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.204 | ||
TLR2 | toll-like receptor 2 | 0.201 | ||
LRRK2 | leucine-rich repeat kinase 2 | 0.199 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.199 | ||
KCNIP2 | Kv channel interacting protein 2 | 0.194 | ||
BAX | BCL2-associated X protein | 0.184 | Human | |
IL8 | interleukin 8 | 0.179 | ||
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.178 | ||
IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.170 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.159 | Rat | |
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.159 | Human | |
MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.156 | ||
MAPK9 | mitogen-activated protein kinase 9 | 0.155 | Human | |
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.154 | ||
DUSP1 | dual specificity phosphatase 1 | 0.151 | ||
C9orf89 | chromosome 9 open reading frame 89 | 0.151 | ||
LY96 | lymphocyte antigen 96 | 0.148 | ||
JUN | jun proto-oncogene | 0.147 | ||
CHUK | conserved helix-loop-helix ubiquitous kinase | 0.138 | ||
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.136 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.132 | ||
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 0.125 | ||
BAD | BCL2-associated agonist of cell death | 0.121 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.119 | ||
TLR4 | toll-like receptor 4 | 0.118 | ||
FAM101B | family with sequence similarity 101, member B | 0.118 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.115 | ||
VAC14 | Vac14 homolog (S. cerevisiae) | 0.108 | ||
FLNA | filamin A, alpha | 0.106 | ||
HSPB1 | heat shock 27kDa protein 1 | 0.105 | ||
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.100 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.099 | ||
HSPA1B | heat shock 70kDa protein 1B | 0.093 | ||
CRYAB | crystallin, alpha B | 0.092 | ||
AR | androgen receptor | 0.091 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.090 | ||
PIAS4 | protein inhibitor of activated STAT, 4 | 0.084 | ||
TRIM21 | tripartite motif containing 21 | 0.083 | ||
TNF | tumor necrosis factor | 0.083 | ||
PLAT | plasminogen activator, tissue | 0.082 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.082 | ||
CSTA | cystatin A (stefin A) | 0.079 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.076 | ||
MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.076 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.075 | Human | |
TLR1 | toll-like receptor 1 | 0.074 | Human | |
MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.073 | ||
CTSS | cathepsin S | 0.073 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.071 | ||
IRF7 | interferon regulatory factor 7 | 0.069 | Human | |
ARRB1 | arrestin, beta 1 | 0.069 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.068 | ||
BCL2A1 | BCL2-related protein A1 | 0.067 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.066 | ||
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.063 | ||
IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.063 | ||
GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.062 | Human | |
IFI16 | interferon, gamma-inducible protein 16 | 0.061 | ||
MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.061 | ||
COL1A2 | collagen, type I, alpha 2 | 0.060 | ||
ADAMTSL4 | ADAMTS-like 4 | 0.060 | ||
IER2 | immediate early response 2 | 0.060 | ||
MYH9 | myosin, heavy chain 9, non-muscle | 0.057 | ||
HDAC4 | histone deacetylase 4 | 0.055 | Rat | |
RGS2 | regulator of G-protein signaling 2, 24kDa | 0.054 | ||
CARD11 | caspase recruitment domain family, member 11 | 0.053 | ||
IFI35 | interferon-induced protein 35 | 0.052 | ||
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.052 | ||
BBC3 | BCL2 binding component 3 | 0.049 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.049 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.048 | ||
ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.047 | ||
ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.047 | ||
LMNA | lamin A/C | 0.042 | ||
SQSTM1 | sequestosome 1 | 0.041 | ||
SPHK1 | sphingosine kinase 1 | 0.041 | ||
ZYX | zyxin | 0.041 | ||
MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.040 | Human | |
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.040 | ||
IGFBP3 | insulin-like growth factor binding protein 3 | 0.040 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.040 | ||
RNF144B | ring finger protein 144B | 0.039 | ||
SNAI1 | snail homolog 1 (Drosophila) | 0.039 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.038 | ||
EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.037 | ||
VIM | vimentin | 0.037 | ||
THBS1 | thrombospondin 1 | 0.037 | ||
LMO4 | LIM domain only 4 | 0.036 | ||
MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.036 | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.036 | ||
ITGB1BP1 | integrin beta 1 binding protein 1 | 0.034 | ||
MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 | 0.034 | ||
HSPA1A | heat shock 70kDa protein 1A | 0.034 | ||
FAM107A | family with sequence similarity 107, member A | 0.034 | ||
PLSCR1 | phospholipid scramblase 1 | 0.032 | ||
BTRC | beta-transducin repeat containing | 0.032 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.031 | Human | |
C1orf93 | chromosome 1 open reading frame 93 | 0.030 | ||
SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.030 | ||
MKNK1 | MAP kinase interacting serine/threonine kinase 1 | 0.030 | ||
FSTL1 | follistatin-like 1 | 0.030 | ||
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.029 | ||
CD63 | CD63 molecule | 0.029 | ||
MPRIP | myosin phosphatase Rho interacting protein | 0.029 | ||
NOTCH1 | notch 1 | 0.029 | ||
TRAF3IP1 | TNF receptor-associated factor 3 interacting protein 1 | 0.029 | ||
GNB5 | guanine nucleotide binding protein (G protein), beta 5 | 0.028 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.028 | ||
SGTA | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha | 0.028 | ||
ITGA6 | integrin, alpha 6 | 0.028 | ||
IRF3 | interferon regulatory factor 3 | 0.028 | Human | |
FLNB | filamin B, beta | 0.027 | ||
SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.027 | ||
IL1R2 | interleukin 1 receptor, type II | 0.027 | ||
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.027 | Human | |
MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.026 | ||
TP53BP2 | tumor protein p53 binding protein, 2 | 0.026 | ||
DUSP9 | dual specificity phosphatase 9 | 0.026 | ||
TPM1 | tropomyosin 1 (alpha) | 0.026 | ||
MIDN | midnolin | 0.026 | ||
NUCB2 | nucleobindin 2 | 0.025 | ||
PIAS1 | protein inhibitor of activated STAT, 1 | 0.025 | ||
IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.025 | ||
CARD16 | caspase recruitment domain family, member 16 | 0.025 | ||
IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.024 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.024 | ||
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.024 | ||
IL15RA | interleukin 15 receptor, alpha | 0.023 | ||
APP | amyloid beta (A4) precursor protein | 0.023 | ||
EDN1 | endothelin 1 | 0.023 | ||
HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.023 | ||
CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.023 | ||
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.023 | ||
MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.023 | Human | |
TICAM2 | toll-like receptor adaptor molecule 2 | 0.023 | ||
DBN1 | drebrin 1 | 0.022 | ||
MYL9 | myosin, light chain 9, regulatory | 0.022 | ||
EGR3 | early growth response 3 | 0.022 | ||
TRAF6 | TNF receptor-associated factor 6 | 0.022 | ||
ENG | endoglin | 0.021 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.021 | ||
ISG20 | interferon stimulated exonuclease gene 20kDa | 0.020 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.020 | ||
CPNE6 | copine VI (neuronal) | 0.020 | ||
RNR2 | l-rRNA | 0.020 | ||
BCL2L2 | BCL2-like 2 | 0.020 | Human | |
IL15 | interleukin 15 | 0.020 | ||
PKN1 | protein kinase N1 | 0.020 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.020 | ||
MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.020 | ||
HTT | huntingtin | 0.020 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.019 | ||
CREBBP | CREB binding protein | 0.019 | ||
MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.019 | Human | |
SP1 | Sp1 transcription factor | 0.019 | ||
TPM4 | tropomyosin 4 | 0.019 | ||
SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.019 | ||
LOX | lysyl oxidase | 0.019 | ||
EHD1 | EH-domain containing 1 | 0.018 | ||
RPS6KA4 | ribosomal protein S6 kinase, 90kDa, polypeptide 4 | 0.018 | ||
TRIM22 | tripartite motif containing 22 | 0.018 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.018 | Rat | |
EGLN1 | egl nine homolog 1 (C. elegans) | 0.018 | ||
HSPB2 | heat shock 27kDa protein 2 | 0.018 | ||
TMEM11 | transmembrane protein 11 | 0.018 | ||
KIAA1377 | KIAA1377 | 0.018 | ||
CLSPN | claspin | 0.018 | ||
IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 0.018 | ||
KIF1C | kinesin family member 1C | 0.018 | ||
TTN | titin | 0.018 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.018 | Rat | |
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.018 | ||
GADD45B | growth arrest and DNA-damage-inducible, beta | 0.017 | Human | |
STX11 | syntaxin 11 | 0.017 | ||
AMBP | alpha-1-microglobulin/bikunin precursor | 0.017 | ||
ORM1 | orosomucoid 1 | 0.017 | ||
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.017 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.017 | ||
OPTN | optineurin | 0.017 | ||
UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.017 | ||
KYNU | kynureninase | 0.017 | ||
LY86 | lymphocyte antigen 86 | 0.017 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.017 | ||
IL1A | interleukin 1, alpha | 0.016 | Human | |
MAPK3 | mitogen-activated protein kinase 3 | 0.016 | ||
CD9 | CD9 molecule | 0.016 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.016 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.016 | ||
PML | promyelocytic leukemia | 0.016 | ||
INHBA | inhibin, beta A | 0.016 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.016 | Rat | |
EFHD2 | EF-hand domain family, member D2 | 0.016 | ||
NMI | N-myc (and STAT) interactor | 0.016 | ||
TGOLN2 | trans-golgi network protein 2 | 0.016 | ||
VNN2 | vanin 2 | 0.016 | ||
MAPK15 | mitogen-activated protein kinase 15 | 0.016 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.016 | ||
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.015 | ||
IL10 | interleukin 10 | 0.015 | ||
VDAC1 | voltage-dependent anion channel 1 | 0.015 | ||
ELK1 | ELK1, member of ETS oncogene family | 0.015 | ||
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.015 | ||
RXRA | retinoid X receptor, alpha | 0.015 | ||
FGA | fibrinogen alpha chain | 0.015 | ||
MT2A | metallothionein 2A | 0.015 | ||
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 0.015 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.015 | ||
VTN | vitronectin | 0.015 | ||
XPO7 | exportin 7 | 0.015 | ||
TIFA | TRAF-interacting protein with forkhead-associated domain | 0.015 | ||
DUSP16 | dual specificity phosphatase 16 | 0.015 | ||
ADM | adrenomedullin | 0.014 | ||
KCNIP1 | Kv channel interacting protein 1 | 0.014 | ||
IRF8 | interferon regulatory factor 8 | 0.014 | Human | |
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.014 | ||
BTK | Bruton agammaglobulinemia tyrosine kinase | 0.014 | ||
RAI1 | retinoic acid induced 1 | 0.014 | ||
SFN | stratifin | 0.014 | ||
EZR | ezrin | 0.014 | ||
GLIS2 | GLIS family zinc finger 2 | 0.014 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.014 | ||
ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.014 | ||
KCTD17 | potassium channel tetramerisation domain containing 17 | 0.014 | ||
FHL2 | four and a half LIM domains 2 | 0.014 | ||
CD14 | CD14 molecule | 0.013 | ||
S100A9 | S100 calcium binding protein A9 | 0.013 | ||
RB1 | retinoblastoma 1 | 0.013 | ||
POU2F2 | POU class 2 homeobox 2 | 0.013 | ||
PSEN1 | presenilin 1 | 0.013 | ||
IL18 | interleukin 18 (interferon-gamma-inducing factor) | 0.013 | ||
TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.013 | ||
OBSL1 | obscurin-like 1 | 0.013 | ||
IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.013 | ||
DUSP4 | dual specificity phosphatase 4 | 0.013 | ||
HDAC5 | histone deacetylase 5 | 0.013 | ||
TLR6 | toll-like receptor 6 | 0.013 | Human | |
EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 0.013 | ||
SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.013 | ||
IL4R | interleukin 4 receptor | 0.013 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.012 | ||
MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.012 | ||
PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.012 | ||
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.012 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.012 | ||
HCK | hemopoietic cell kinase | 0.012 | ||
MSR1 | macrophage scavenger receptor 1 | 0.012 | ||
ALPL | alkaline phosphatase, liver/bone/kidney | 0.012 | ||
CTGF | connective tissue growth factor | 0.012 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.012 | ||
TUBB2B | tubulin, beta 2B | 0.012 | ||
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.012 | ||
MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.012 | ||
C4orf14 | chromosome 4 open reading frame 14 | 0.012 | ||
IRF2 | interferon regulatory factor 2 | 0.012 | Human | |
PARD3B | par-3 partitioning defective 3 homolog B (C. elegans) | 0.012 | ||
CYBB | cytochrome b-245, beta polypeptide | 0.012 | ||
ZBTB48 | zinc finger and BTB domain containing 48 | 0.012 | ||
HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.012 | ||
MR1 | major histocompatibility complex, class I-related | 0.012 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.012 | ||
CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.012 | ||
TAOK2 | TAO kinase 2 | 0.011 | ||
PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.011 | ||
STAP2 | signal transducing adaptor family member 2 | 0.011 | ||
BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.011 | ||
SMAD1 | SMAD family member 1 | 0.011 | ||
NPC2 | Niemann-Pick disease, type C2 | 0.011 | ||
IL10RB | interleukin 10 receptor, beta | 0.011 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.011 | ||
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | ||
CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.011 | ||
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.011 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.011 | ||
BATF | basic leucine zipper transcription factor, ATF-like | 0.011 | ||
VWF | von Willebrand factor | 0.011 | ||
JAK3 | Janus kinase 3 | 0.011 | ||
C1orf38 | chromosome 1 open reading frame 38 | 0.011 | ||
MDFI | MyoD family inhibitor | 0.011 | ||
SQRDL | sulfide quinone reductase-like (yeast) | 0.011 | ||
TNFRSF10D | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain | 0.011 | Human | |
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.011 | ||
MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 0.010 | ||
TFEC | transcription factor EC | 0.010 | ||
CATSPER1 | cation channel, sperm associated 1 | 0.010 | ||
MEF2C | myocyte enhancer factor 2C | 0.010 | ||
BBS1 | Bardet-Biedl syndrome 1 | 0.010 | ||
MXD1 | MAX dimerization protein 1 | 0.010 | ||
KIAA1274 | KIAA1274 | 0.010 | ||
PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.010 | ||
SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.010 | ||
CD47 | CD47 molecule | 0.010 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.010 | ||
NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.010 | ||
ALDOB | aldolase B, fructose-bisphosphate | 0.010 | ||
TGFB2 | transforming growth factor, beta 2 | 0.010 | ||
WWTR1 | WW domain containing transcription regulator 1 | 0.010 |